Board of Directors
 |
J. Michael Pearson Chairman of the Board |
 |
Robert A. Ingram Lead Director, Valeant Pharmaceuticals International, Vice Chairman Pharmaceuticals of GlaxoSmithKline |
 |
Richard H. Koppes Of Counsel to Jones Day |
 |
Lawrence N. Kugelman Director, Coventry Healthcare |
 |
Theo Melas-Kyriazi Chief Financial Officer, Levitronix LLC |
 |
Norma A. Provencio President and Owner, Provencio Advisory Services Inc. |
 |
G. Mason Morfit Partner, ValueAct Capital |
 |
Anders Lönner Group President and Chief Executive Officer, Meda AB |
 |
Steve F. Stefano Senior Vice President of GlaxoSmithKline's Payor Markets Division |
Senior Management
|
J. Michael Pearson Chairman and Chief Executive Officer |
 |
Elisa Karlson Executive Vice President and Chief Administrative Officer |
 |
Steve T. Min Executive Vice President, General Counsel and Corporate Secretary |
 |
Peter J. Blott Executive Vice President, Chief Financial Officer |
 |
Rajiv De Silva Chief Operating Officer of Specialty Pharmaceuticals |
 |
Richard K. Masterson Executive Vice President, Commercial Development |
 |
Bhaskar Chaudhuri President, Valeant Pharmaceuticals International |